Respiratory devices

Beroe LiVE.Ai™

AI-powered self-service platform for all your sourcing decision needs across 1,200+ categories like Respiratory devices.

Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.

Schedule a Demo

Respiratory devices Market Monitoring Dashboard

Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™

Schedule a Demo

Respiratory devices Industry Benchmarks

Savings Achieved

(in %)

The average annual savings achieved in Respiratory devices category is 4.85%

Payment Terms

(in days)

The industry average payment terms in Respiratory devices category for the current quarter is 54.3 days

Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™

Category Strategy and Flexibility

Engagement Model

Supply Assurance

Sourcing Process

Supplier Type

Pricing Model

Contract Length


Lead Time

Supplier Diversity

Targeted Savings

Risk Mitigation

Financial Risk



Geopolitical Risk

Cost Optimization

Price per Unit Competitiveness

Specification Leanness

Minimum Order Quality

Payment Terms

Inventory Control

Schedule a Demo
Meet Abi

The World’s first Digital Market Analyst

    Meet Abi

    The World’s first Digital Market Analyst

    Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions

    Abi is now supercharged with GPT4 AI engine. Enjoy the ease of ChatGPT, now on Abi

    Respiratory devices Market Intelligence

    global market outlook

      • The global respiratory care devices market was valued at ~$25.2 billion in 2020 and is projected to reach ~$39 billion by 2025 growing at a CAGR of ~9.5 percent Y-o-Y during the forecast period of 2021-2025.
      • The therapeutic devices segment dominates the global respiratory care devices market and valued at ~ $13.77 billion in the year 2020.
      • North America accounted for the major market share of ~41 percent in the year 2020.
      • Europe is the second largest region globally for consumption of respiratory care devices, due to its geriatric population and rising chronic respiratory diseases.
      • Major respiratory device players have their presence in the US region, accounting for more than 30 percent of the global market share.

    Respiratory devices market frequently asked questions

    Market players are outsourcing the manufacturing of various respiratory devices, including mechanical ventilators, oxygen concentrators, and PAP devices, to reduce the burden on their capital resources while maintaining their market competitiveness. Furthermore, they are entering into mergers and acquisitions (M&A) with MedTech clients and medical equipment manufacturers to diversify their product pipelines and improve their global footprint.

    Considerable capital requisites and high medical and R&D expertise required to develop complex invasive or mechanical ventilators, CPAP devices, and connected diagnostic devices make it difficult for new entrants to compete with other market players.

    In general, market players encounter various obstacles, such as regional regulatory compliance, quality-focused manufacturing facilities, and having a global footprint to deliver after-sales services.

    The global respiratory devices market registered around $23 Bn in 2019 and will peg nearly $33 Bn by 2023, at a tremendous 9.1% CAGR.

    The increasing geriatric population in tandem with a notable rise in chronic obstructive pulmonary disorders (COPD) and sleep apnea/hypopnea syndrome (SAHS) are primarily fueling the market growth of respiratory devices.

    Market players are investing their resources in multiple tech advances, such as enhanced portable respiratory devices, e-Nose, Bluetooth-enabled, and fingertip pulse oximeters.

    Respiratory devices market report transcript

    Respiratory Devices Global Market Outlook:

    • The global respiratory care devices market was valued at ~$23.6 Billion in 2021 and is projected to reach ~$27.6 billion by 2026 growing at a CAGR of ~8.5 percent Y-o-Y during the forecast period of 2023 –2026

    • An alarming rise in the number of chronic obstructive pulmonary disorder (COPD) and a rapid visible increase in the diagnosis rate of sleep apnea/hypopnea syndrome (SAHS) and rising geriatric population drive the demand in the market

    • While the above factors collectively contribute to the demand for respiratory assistance therapy and devices, particularly continuous positive airway pressure (CPAP), the sudden outbreak of the global COVID-19 pandemic boosts the global CPAP market landscape

    Segment and Regional Analysis : Respiratory Devices

    Segmentation Analysis

    • By Type: Therapeutic devices segment dominates the global respiratory care devices market

    • By Application: Chronic obstructive pulmonary disease (COPD) segment held the largest market share of 33 percent in the year 2021. The high prevalence of COPD and the growing number of deaths caused by COPD are expected to drive the demand for respiratory care devices during the forecast period

    • By End-use Segment: Hospitals form the largest end-user segment ~70 percent of the respiratory care devices market in 2023. The home care segment is projected to grow at the highest CAGR of 9–10 percent and the growth is mainly due to the development of portable and lightweight respiratory care devices

    Regional Analysis

    • North America accounted for the major market share of ~41 percent in the year 2023

    • Europe is the second largest market with a market share of 30 percent globally and the key market share holder is Germany, followed by UK and France

    • APAC region is projected to grow at the highest CAGR of 9 percent during the forecast period 2023–2026. Low infrastructure and treatment costs and the availability of highly educated physicians have driven medical companies to APAC countries, particularly India and China

    Porter's Analysis on Respiratory Devices

    Supplier Power

    • Respiratory products is a medium fragmented market with suppliers having category expertise, diverse variants of products, and competitive services offerings across regions

    • Top suppliers existing in the market have high technical knowledge and are focusing on new innovative product launches through partnership with Medtech clients

    Barriers to New Entrants

    • Huge medical, R&D expertise, capital requirements make it difficult for new entrants for complex invasive or mechanical ventilators, CPAP devices, connected diagnostic devices

    • Havin global distribution footprint to offer after sales services, meeting regional specific regulatory requirements, and having quality met manufacturing facilities are the key challenges for medium to complex medical

    Intensity of Rivalry

    • Technological advancements in the form of E-Nose, enhanced portable respiratory devices, Bluetooth-enabled and fingertip pulse oximeters will play a major role in driving innovation in the market

    Threat of Substitutes

    • As such there are no substitutes to critical medical ventilators, PAP devices, oxygen concentrators; but innovation in miniaturized connected devices with various software and components will have impact on the market threat

    Buyer Power

    • Bargaining power for medical device clients is medium to low, as the number purchased by individual customer in general is low

    • Lower switching power, owing to higher cost and technical knowledge associated with the devices

    Cost Structure Analysis : Respiratory Devices

    • Technological advancements, like finger pulse oximeters and Bluetooth enabled pulse oximeters, drive the demand for respiratory care devices in the market, hence raw materials and components contribute to the major portion of manufacturing, since the critical components are important, which needs to work each time of usage without any failure

    • Raw Materials & Components Cost: Miniaturization, portable devices are the key innovations in the industry with more accuracy & efficiency drives the critical components price upwards in the respiratory care devices industry globally

    • Labor and Technology Cost: Adoption of latest technology drives the spend on R&D to develop new products will also lead to increase in cost of the products. 3D manufacturing & AI technology advancement require workforces with technical knowledge

    Interesting Reads:

    Discover the world of market intelligence and how it can elevate your business strategies.

    Learn more about how market intelligence can enable informed decision-making, help identify growth opportunities, manage risks, and shape your business's strategic direction.

    Get Ahead with AI-Enabled Market Insights Schedule a Demo Now

    Schedule a Demo Now